S. ÜNAL Et Al. , "Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma," 8th Multidisciplinary Cancer Research Congress , Turkey, 2021
ÜNAL, S. Et Al. 2021. Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma. 8th Multidisciplinary Cancer Research Congress , (Turkey).
ÜNAL, S., ARSLAN ESERYEL, S., GÜVEN, Ü., ŞAHİN, A., YILMAZ GÖLER, A. M., ATASOY, B. M., ... GÜNDÜZ, O.(2021). Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma . 8th Multidisciplinary Cancer Research Congress, Turkey
ÜNAL, SEMRA Et Al. "Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma," 8th Multidisciplinary Cancer Research Congress, Turkey, 2021
ÜNAL, SEMRA Ü. Et Al. "Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma." 8th Multidisciplinary Cancer Research Congress , Turkey, 2021
ÜNAL, S. Et Al. (2021) . "Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma." 8th Multidisciplinary Cancer Research Congress , Turkey.
@conferencepaper{conferencepaper, author={SEMRA ÜNAL YILDIRIM Et Al. }, title={Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma}, congress name={8th Multidisciplinary Cancer Research Congress}, city={}, country={Turkey}, year={2021}}